However, in an environment where physicians’ and payers’ interactions with biopharma are increasingly scrutinised, participants are becoming wary of their involvement and association with pharmaceutical companies.
Yet the benefits of gaining insights from thought leaders to shape brand strategy continues to be essential, even invaluable.
Technology can help in the identification of key individuals, and can be leveraged to facilitate the development of a sophisticated database which can be interrogated using multiple and evolving criteria across a broad range of therapeutic areas. Imagine being able to identify current and future thought leaders and redefine your search criteria on an ongoing basis as objectives evolve… All at the click of a button.
From evolving clinical development strategy to designing a clinical trial programme, defining the most critical clinical endpoints, incorporating the most relevant value outcomes for payers or establishing consensus in terms of evolving treatment guidelines, the leading minds in a specific therapeutic area can provide valuable insights throughout a product’s lifecycle, helping to guide brand strategy in terms of clinical development and market access.
In a rapidly changing, compliance driven and economically challenging environment flexibility is key. So, whether conducting double blinded in-depth interviews, designing and fielding web based surveys, facilitating a series of web-based virtual ad boards over time, or conducting traditional in-person onsite advisory board meetings, alternate approaches to gathering game-changing insight exist.
We at Mirador Analytics work closely with clients to determine the best approach to gain critical insight, we do not force clients into using a program which may not match their needs.
Do you think your company could benefit from our Thought Leader Identification Services?
Check out our tools and services tab for more information on our Individual Identification Database, or get in touch via the contact page. We’d be happy to talk to you.